Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.